Eduardo M Castaño
Eduardo M Castaño
Підтверджена електронна адреса в leloir.org.ar - Домашня сторінка
Назва
Посилання
Посилання
Рік
β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy
C Soto, EM Sigurdsson, L Morelli, RA Kumar, EM Castaño, B Frangione
Nature medicine 4 (7), 822-826, 1998
10091998
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
T Wisniewski, EM Castano, A Golabek, T Vogel, B Frangione
The American journal of pathology 145 (5), 1030, 1994
5961994
Differences between vascular and plaque core amyloid in Alzheimer's disease
F Prelli, E Castano, GG Glenner, B Frangione
Journal of neurochemistry 51 (2), 648-651, 1988
3921988
The-helical to-strand transition in the amino-terminal fragment of the amyloid-peptide modulates amyloid formation
C Soto, EM Castaño, B Frangione, NC Inestrosa
Journal of Biological Chemistry 270 (7), 3063-3067, 1995
3911995
Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease
SG Van Duinen, EM Castano, F Prelli, GT Bots, W Luyendijk, B Frangione
Proceedings of the National Academy of Sciences 84 (16), 5991-5994, 1987
3691987
Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E
EM Castano, F Prelli, T Wisniewski, A Golabek, RA Kumar, C Soto, ...
Biochemical Journal 306 (2), 599-604, 1995
3181995
Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease
AE Roher, CL Esh, TA Kokjohn, EM Castaño, GD Van Vickle, WM Kalback, ...
Alzheimer's & Dementia 5 (1), 18-29, 2009
3132009
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
F Coria, E Castano, F Prelli, M Larrondo-Lillo, S Van Duinen, ...
Laboratory investigation; a journal of technical methods and pathology 58 (4 …, 1988
2981988
Degradation of soluble amyloid β-peptides 1–40, 1–42, and the Dutch variant 1–40Q by insulin degrading enzyme from Alzheimer disease and control brains
A Pérez, L Morelli, JC Cresto, EM Castaño
Neurochemical research 25 (2), 247-255, 2000
2912000
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease β-protein
EM Castaño, J Ghiso, F Prelli, PD Gorevic, A Migheli, B Frangione
Biochemical and biophysical research communications 141 (2), 782-789, 1986
2841986
Human amyloidosis, Alzheimer disease and related disorders
EM Castano, B Frangione
Laboratory investigation 58 (2), 122-132, 1988
242*1988
Defective ubiquitination of cerebral proteins in Alzheimer's disease
M López Salon, L Morelli, EM Castaño, EF Soto, JM Pasquini
Journal of neuroscience research 62 (2), 302-310, 2000
2372000
Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects
EM Castaño, AE Roher, CL Esh, TA Kokjohn, T Beach
Neurological research 28 (2), 155-163, 2006
2222006
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis
RL Patton, WM Kalback, CL Esh, TA Kokjohn, GD Van Vickle, DC Luehrs, ...
The American journal of pathology 169 (3), 1048-1063, 2006
2032006
Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic Xray diffraction pattern
PD Gorevic, EM Castano, R Sarma, B Frangione
Biochemical and biophysical research communications 147 (2), 854-862, 1987
1951987
Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease
W Kalback, C Esh, EM Castaño, A Rahman, T Kokjohn, DC Luehrs, L Sue, ...
Neurological research 26 (5), 525-539, 2004
1822004
Fibrillogenesis of synthetic amyloid-β peptides is dependent on their initial secondary structure
C Soto, EM Castaño, RA Kumar, RC Beavis, B Frangione
Neuroscience letters 200 (2), 105-108, 1995
1751995
Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
F Coria, EM Castano, B Frangione
The American journal of pathology 129 (3), 422, 1987
1591987
The conformation of Alzheimer's β peptide determines the rate of amyloid formation and its resistance to proteolysis
C Soto, EM CASTAÑO
Biochemical Journal 314 (2), 701-707, 1996
1551996
Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease
D Watson, E Castaño, TA Kokjohn, YM Kuo, Y Lyubchenko, D Pinsky, ...
Neurological research 27 (8), 869-881, 2005
1322005
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20